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Abstract 
Several co-crystals of the TFIIB-RNAP II interface exist suggesting the TFIIB linker region to 
penetrate the active centre, yet the understanding of the resulting protein-protein interactions 
and their impact on the transcription cycle has remained elusive. Promoter-independent abortive 
initiation assays exploit the intrinsic ability of RNAP enzymes to initiate transcription from nicked 
DNA templates and measuring the phosphodiester bond formation they catalyse. These assays can 
be used to measure the effect of transcription factors and mutations on the rate of the catalytic 
reaction. Notably, they have served to reveal and characterise a significant stimulation activity of 
TFIIB on RNAP that was previously unknown. 
 
Introduction 
The central dogma of biology renders transcription a fundamental process that is indispensable in all 
three domains of life (i.e. bacteria, eukaryotes and archaea). RNA polymerases use rNTPs as building 
blocks to synthesise single-stranded RNA from a double-stranded DNA template. Although RNAPs 
are at the core of transcription, they cannot function autonomously, and require the aid of basal 
transcription factors. These factors guarantee a basal level of transcription.  
The transcription cycle is a multi-step process which can be broadly divided into three stages, 
namely i) initiation, ii) elongation, and iii) termination (reviewed in (1)). Transcription initiation is the 
most highly regulated of the three stages with a number of events required to occur prior to full 
length transcript production. First, a preinitiation complex (PIC) consisting of a defined set of basal 
transcription factors assembles at the promoter of a gene. The basal transcription factors that 
constitute the PIC find the promoter of a gene (TBP), bridge between TBP/DNA and RNAP II (TFIIB), 
stabilise the ternary complex (TFIIA), change DNA topology (TFIIF), or assist in promoter melting 
(TFIIE, TFIIH) (2-4). The initial ‘set’ of transcription components at the promoter of a non-melted 
template is referred to as ‘closed complex’ (3, 5, 6). The entire complex as well as RNAP itself must 
undergo a series of structural rearrangements that ultimately lead to template melting and 
formation of the transcription bubble (7). Loading of DNA within the active site accompanies ‘open 
complex’ formation (3, 5, 6). The initial phase of transcription is inefficient and error-prone yielding 
short transcripts of 8 to 11nt in length, termed ‘abortive initiation’ (8-14). Further structural 
rearrangements result in promoter escape and finally RNAP enters the elongation phase (15). The 
mechanistic details of transcription initiation (i.e. formation of a promoter complexes and structural 
rearrangements required to establish the transcription bubble and to make RNAP competent for 
transcription) are fundamental and follow the same molecular principles in bacteria, archaea and 
eukaryotes (16, 17).   
 
The TFIIB/RNAP interface: advantages of biochemical analysis strategies 
The investigation of protein-protein interactions within the PIC relies to a large extent on x-ray 
crystallography. Structural snapshots of different stages of the transcription cycle exist and provide 
us with some insight into functional relationships. Biochemical analysis strategies complement 
structural data and promote our understanding of the dynamics of the system. We were particularly 
interested in the interface of RNAP II and TFIIB which – together with TBP – is indispensable for 
promoter-directed transcription both in eukaryotes and archaea (18-20).  
TFIIB comprises a tripartite structure, (i) a C-terminal core domain to interact with TBP and promoter 
DNA, (ii) an N-terminal zinc-ribbon domain to interact with and recruit RNAP and (iii) a flexible linker 
domain in between that has been demonstrated to stimulate the catalytic activity of RNAP (21-24). 
Several yeast TFIIB-RNAP II co-crystals exist showing glimpses of the interactions between the TFIIB 
linker and the RNAP II surface and suggesting that the TFIIB linker penetrates the active centre cleft 
(22-24). Biochemical analyses demonstrated that the linker domain of TFIIB actively contributes to 
the catalytic activity of RNAP which in its presence is substantially higher than in its absence (25-27). 
The resolution of these RNAP II-TFIIB co-crystals is, however, poor and insufficient to either reveal or 
fully explain all the activities that TFIIB has in a PIC.  
By applying a saturation mutagenesis approach (i.e. by substituting every amino acid residue of a 
given sequence by all 19 other amino acids) we were able to investigate the influence that TFIIB has 
on the catalytic activity of RNAP (26, 27). This approach was facilitated by switching to a model 
system that at several occasions has proven its high degree of accessibility. The RNAP of the 
hyperthermophilic archaeon Methanocaldococcus jannaschii (mjRNAP) is similar to eukaryotic RNAP 
II both in subunit structure and function. A lifestyle in extreme environments has required the 
adaptation of the organism’s proteins to high temperatures and pressures which has given them an 
exceptional degree of robustness. The experimental handling of these proteins is therefore much 
easier and has prompted the successful in vitro assembly of the mjRNAP from recombinantly 
produced subunits (28). The archaeal counterparts of TBP (mjTBP), TFIIB (mjTFIIB) and TFIIE (mjTFIIE) 
can be studied in this system as well (25). This provided us with a powerful tool that is readily 
accessible to saturation mutagenesis approaches during which we can study protein-protein 
interactions in an unbiased manner and on a single-residue level. Saturation mutagenesis has given 
us extensive insight into the protein dynamics accompanying the nucleotide addition cycle catalysed 
by mjRNAP that structural data have failed to uncover (29, 30). Given the success in this system, we 
recently included the interface of the mjTFIIB linker and mjRNAP into our studies to further 
investigate the stimulation effect of the linker on mjRNAP activity (26).  
 
Different types of transcription assays to assess different aspects of 
transcription 
The catalytic activity of RNAP enzymes is usually assessed by measuring the production of RNA 
transcripts under defined reaction conditions. The setup of different types of such transcription 
assays accommodates the need to investigate different aspects and stages of the transcription cycle. 
Promoter-dependent assays make use of a well-defined DNA template which can be linear or 
plasmid-based. They measure the rate of transcription that occurs from a particular promoter and 
rely on the presence of transcription factors and on a PIC forming at that promoter. These types of 
assays are biased by promoter strength. RNAP recruitment, promoter opening, promoter escape etc 
are activities of several transcription factors. Therefore, masking effects and redundancies occur 
within a PIC and make it difficult to appreciate the contribution of individual transcription factors.  
In contrast, promoter-independent assays constitute a minimal in vitro system and do not rely on 
any sequence properties and they can test purely for the catalytic activity of RNAP without the 
interference of other transcription factor activities. Transcription is randomly initiated at 3’ 
overhangs or nicks in DNA templates. RNAPs do have a basal affinity to DNA and the availability of 
such nicks abolishes the need for precise promoter positioning. The loose DNA ends can enter the 
catalytic site of RNAP without the requirements of transcription factors to achieve and template 
melting. Such assays are thus particularly suitable to study the fundamental catalytic mechanism of 
RNAP. In combination with recombinant enzymes that can be manipulated easily, the contribution of 
individual protein domains or – through mutagenesis – individual residues can be analysed. This type 
of assays also sets a clear standard for RNAP activity by measuring it under particular experimental 
conditions and it is suitable to assess how the activity of RNAP is affected upon changing 
experimental conditions e.g. the presence of transcription factors. 
In a minimal promoter-independent transcription system measuring randomly initiated run-off 
transcription, mjTFIIB was found to stimulate transcript production significantly (25). We found that 
this effect was even more pronounced in a promoter-independent abortive initiation assay (Figure 
1B,C) which allowed us to study the initial phosphodiester bond formation and removed additional 
variables such as sliding of the RNAP across the template, bubble collapse, template melting etc.   
 
An in vitro assay to test for RNAP catalytic activity using a promoter-
independent abortive initiation assay 
For this type of abortive initiation assays we use activated calf thymus DNA (i.e. genomic DNA that 
has been treated with DNase I according to a method developed by Aposhian and Kornberg (31)  to 
introduce nicks) as a nonspecific template). In the presence of any dinucleotide priming agent (e.g. 
GpC) and a single nucleotide substrate (e.g. UTP), short, ‘abortive’ transcripts are produced (Figure 
1A). We used this assay to study interactions between mjRNAP and mjTFIIB (Figure 1B,C, Figure 2). 
With small modifications, the protocol can be used for E. coli or T7 RNAP as well. We carried out our 
reactions in total volumes of 25 l containing 1 x transcription buffer (M. jannaschii: 50mM Tris-Cl 
[pH7.5], 75mM KCl, 25mM MgCl2; E. coli: 40mM Tris-Cl [pH7.5], 150 mM KCl, 10 mM MgCl2, 0.01 % 
Triton-X100; T7: 80 mM Tris-Cl [pH7.9], 12 mM MgCl2, 4 mM spermidine), 10 mM DTT, 600 ng 
activated calf thymus DNA, 400 M GpC, 10 M unlabelled rUTP and 2.5 Ci a32P-UTP. We used 250-
500 ng mjRNAP and 750-1750 ng mjTFIIB per reaction. The samples were incubated at 65°C – the 
temperature optimum for mjRNAP in this assay. For mesophilic RNAPs such as E. coli RNAP or T7 
RNAP, the reaction was incubated at 37°C. The accumulation of abortive products was time-
dependent and strictly linear over a course of 60 min and we routinely incubated the reactions for 
30 min. To prevent evaporation at high temperatures, a drop of mineral oil was added to seal the 
reaction surface. Portions of the samples were boiled for 2 min in 50 % formamide and 10 l of each 
sample was loaded on a denaturing urea gel and run in 1x TBE for 70-80 min at 225 V. Afterwards, 
the gels were exposed to a Kodak IP screen and read with a Fuji FLA5000 PhosphoImager.   
 
A bioluminescent read-out method suitable for automation 
Abortive initiation assays are conventionally gel-based and thus time-consuming and not applicable 
to high-throughput screenings. Attempts to automate this type of assay have been hampered by the 
short size of abortive transcripts which cannot be separated sufficiently from free nucleotides. 
Therefore an approach was pursued that relies on the determination of the amount of inorganic 
pyrophosphate (PPi) released as a by-product during the transcription reaction. In a series of 
enzymatic reactions, PPi together with adenosine-5’-phosphosulfate (APS) can be converted to ATP 
by ATP-sulfurylase (Figure 3A). ATP is subsequently used by luciferase to activate D-luciferin which, 
in this activated form, can be oxidized to oxyluciferin in a light producing reaction (32). In detail, we 
diluted portions of the (completed) transcription reaction 4-fold in 0.1 U/ml ATP sulfurylase and 
100 M APS. 10 l of each reaction was then mixed with 10 l undiluted ATP assay mix (Sigma) in 
white 384-well plates. Luminescence was measured immediately using a microplate reader. The 
intensity of the bioluminescent signal is directly proportional to the concentration of PPi and is also 
predicted to correlate with the number of transcripts (Figure 3B). Such an approach has been 
developed for sequencing purposes (33-35) as well as for assaying the activity of RNA-dependent 
RNAP(36). We modified this assay to detect abortive transcription activity of DNA-dependent RNAPs 
and obtained reliable results both for E. coli RNAP and T7 RNAP and reached a degree of sensitivity 
which was comparable to gel-based assays (Figure 3 C,D).  
 
 
Conclusions and perspective 
The promoter-independent abortive initiation assay described here measures phosphodiester bond 
formation and is thus a useful tool to assess the fundamental catalytic activity of RNAP enzymes in 
the absence of any auxiliary transcription factors. In its gel-based form, this assay has been 
successfully and extensively used to analyse the interface of the mjTFIIB linker and the mjRNAP 
surface. It has not only complemented structural studies but has also given us novel insight into the 
dynamics of these interactions. The sensitivity of the bioluminescent read-out method is comparable 
to the radioactive read-out and can be carried out in a microtiter plate format. We have 
demonstrated that this is method is suitable to test the catalytic activities of T7 and E. coli RNAP and 
propose that automating the assay on a robotic platform will provide a useful tool for the high-
throughput screening of large numbers of mutants. 
 
Figure Legends: 
 
Figure 1: Promoter-independent abortive initiation assays. 
A. The assay exploits the intrinsic ability of RNAP to initiate from nicked DNA templates in a non-
specific manner. In the presence of a single type of (labelled) rNTP, RNAP catalyses the extension 
of a dinucleotide primer to form a short, labelled, abortive transcript which can be visualised on 
a gel. Pyrophosphate is released as a by-product of the reaction. 
B. Abortive transcripts can be visualised on a gel. In the presence of mjTFIIB, transcripts accumulate 
at a much higher rate. 
C. The rate at which abortive transcripts are produced is time-dependent. 
 
Figure 2: Abortive initiation assays can be used to measure the stimulation effect of mjTFIIB 
mutants on mjRNAP. 
The histogram shows the altered stimulation activity of a full library of point mutations in mjTFIIB 
residue K87 on mjRNAP relative to the stimulation activity obtained with wildtype (wt) TFIIB. Each 
mutant was tested in triplicate. The error bars (representing standard deviations) as well as the 
sample gel underneath illustrate the reproducibility of the results. 
 
Figure 3: A bioluminescent readout method 
A. PPi which is released as a by-product during the transcription reaction and APS are 
converted to ATP by ATP-sulfurylase. The amount of PPi present is proportional to the 
amount of ATP being produced. 
B. Luciferase converts ATP and D-luciferin to adenyl-luciferin which – in a light-producing 
reaction – is oxidised to oxyluciferin. The amount of ATP present is proportional to the 
intensity of the light being produced. 
C. Comparison of RNAP titrations evaluated by the radioactive (red) or the bioluminescent 
(red) read-out methods. The titration curves show comparable sensitivity for both methods 
when tested with E. coli or T7 RNAP. 
D. Gel images of the RNAP titrations analysed in C. 
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